Published in PLoS One on October 10, 2012
Host Response to the Lung Microbiome in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med (2015) 2.97
Topographic diversity of fungal and bacterial communities in human skin. Nature (2013) 2.79
The composition and stability of the vaginal microbiota of normal pregnant women is different from that of non-pregnant women. Microbiome (2014) 2.24
Oligotyping analysis of the human oral microbiome. Proc Natl Acad Sci U S A (2014) 1.56
The altered landscape of the human skin microbiome in patients with primary immunodeficiencies. Genome Res (2013) 1.35
Functions of the skin microbiota in health and disease. Semin Immunol (2013) 1.22
Oral mycobiome analysis of HIV-infected patients: identification of Pichia as an antagonist of opportunistic fungi. PLoS Pathog (2014) 1.13
Indoor-air microbiome in an urban subway network: diversity and dynamics. Appl Environ Microbiol (2014) 1.05
Skin Microbiome Surveys Are Strongly Influenced by Experimental Design. J Invest Dermatol (2016) 0.99
Strain/species identification in metagenomes using genome-specific markers. Nucleic Acids Res (2014) 0.98
Use of 16S rRNA gene for identification of a broad range of clinically relevant bacterial pathogens. PLoS One (2015) 0.94
Transplantation-associated long-term immunosuppression promotes oral colonization by potentially opportunistic pathogens without impacting other members of the salivary bacteriome. Clin Vaccine Immunol (2013) 0.92
The human microbiome in hematopoiesis and hematologic disorders. Blood (2015) 0.91
Meta-omics uncover temporal regulation of pathways across oral microbiome genera during in vitro sugar metabolism. ISME J (2015) 0.89
SPINGO: a rapid species-classifier for microbial amplicon sequences. BMC Bioinformatics (2015) 0.88
Potential role of gastrointestinal microbiota composition in prostate cancer risk. Infect Agent Cancer (2013) 0.86
Longitudinal Evaluation of the Skin Microbiome and Association with Microenvironment and Treatment in Canine Atopic Dermatitis. J Invest Dermatol (2016) 0.83
Cutaneous microbiome effects of fluticasone propionate cream and adjunctive bleach baths in childhood atopic dermatitis. J Am Acad Dermatol (2016) 0.80
The impact of various time intervals on the supragingival plaque dynamic core microbiome. PLoS One (2015) 0.79
Pipeline for amplifying and analyzing amplicons of the V1-V3 region of the 16S rRNA gene. BMC Res Notes (2016) 0.79
Applying Convergent Immunity to Innovative Vaccines Targeting Staphylococcus aureus. Front Immunol (2014) 0.78
Prospecting environmental mycobacteria: combined molecular approaches reveal unprecedented diversity. PLoS One (2013) 0.78
Details Matter: Designing Skin Microbiome Studies. J Invest Dermatol (2016) 0.78
Faecal microbiota characterisation of horses using 16 rdna barcoded pyrosequencing, and carriage rate of clostridium difficile at hospital admission. BMC Microbiol (2015) 0.77
Mycoplasma salivarium as a dominant coloniser of Fanconi anaemia associated oral carcinoma. PLoS One (2014) 0.77
riboFrame: An Improved Method for Microbial Taxonomy Profiling from Non-Targeted Metagenomics. Front Genet (2015) 0.77
Dietary iron depletion at weaning imprints low microbiome diversity and this is not recovered with oral Nano Fe(III). Microbiologyopen (2014) 0.77
A method for culturing Gram-negative skin microbiota. BMC Microbiol (2016) 0.76
Gut microbiome and kidney disease: a bidirectional relationship. Pediatr Nephrol (2016) 0.76
Bacterial Strain Diversity Within Wounds. Adv Wound Care (New Rochelle) (2015) 0.75
RNA virus receptor Rig-I monitors gut microbiota and inhibits colitis-associated colorectal cancer. J Exp Clin Cancer Res (2017) 0.75
Systematic evaluation of immune regulation and modulation. J Immunother Cancer (2017) 0.75
Strategies and Methodologies for Developing Microbial Detoxification Systems to Mitigate Mycotoxins. Toxins (Basel) (2017) 0.75
"The microbiome and immune regulation after transplantation". Transplantation (2016) 0.75
Recent advances in the understanding and management of Klebsiella pneumoniae. F1000Res (2017) 0.75
The Skin Microbiome of Cohabiting Couples. mSystems (2017) 0.75
A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst Biol (2003) 102.57
Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol (2009) 77.55
Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Appl Environ Microbiol (2006) 57.72
SILVA: a comprehensive online resource for quality checked and aligned ribosomal RNA sequence data compatible with ARB. Nucleic Acids Res (2007) 35.65
Structure, function and diversity of the healthy human microbiome. Nature (2012) 30.40
Enterotypes of the human gut microbiome. Nature (2011) 24.36
The ribosomal database project (RDP-II): introducing myRDP space and quality controlled public data. Nucleic Acids Res (2006) 16.26
Reducing the effects of PCR amplification and sequencing artifacts on 16S rRNA-based studies. PLoS One (2011) 12.26
A framework for human microbiome research. Nature (2012) 11.41
Compilation of small ribosomal subunit RNA sequences. Nucleic Acids Res (1990) 11.22
The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis (2005) 9.80
Metagenomic microbial community profiling using unique clade-specific marker genes. Nat Methods (2012) 8.37
Prevalence of Staphylococcus aureus nasal colonization in the United States, 2001-2002. J Infect Dis (2005) 6.78
Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing. Sci Transl Med (2012) 6.63
The new paradigm of flow cell sequencing. Genome Res (2008) 5.81
pplacer: linear time maximum-likelihood and Bayesian phylogenetic placement of sequences onto a fixed reference tree. BMC Bioinformatics (2010) 5.70
Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001-2004. J Infect Dis (2008) 5.41
Reproducibility and quantitation of amplicon sequencing-based detection. ISME J (2011) 2.64
Design of 16S rRNA gene primers for 454 pyrosequencing of the human foregut microbiome. World J Gastroenterol (2010) 2.41
Insensitivity of rapid antigen detection methods and single blood agar plate culture for diagnosing streptococcal pharyngitis. JAMA (1992) 2.20
Selection of primers for optimal taxonomic classification of environmental 16S rRNA gene sequences. ISME J (2012) 1.86
Classification, identification and subtyping of bacteria based on pyrosequencing and signature matching of 16S rDNA fragments. APMIS (2002) 1.52
Fecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in patients and asymptomatic healthy individuals. Infect Control Hosp Epidemiol (2007) 1.29
Rapid molecular identification and subtyping of Helicobacter pylori by pyrosequencing of the 16S rDNA variable V1 and V3 regions. FEMS Microbiol Lett (2001) 1.27
Asymptomatic carriage of Klebsiella pneumoniae producing extended-spectrum beta-lactamase by patients in a neurological early rehabilitation unit: management of an outbreak. J Hosp Infect (2001) 1.00
Accurate taxonomic assignment of short pyrosequencing reads. Pac Symp Biocomput (2010) 0.92
Reconciling taxonomy and phylogenetic inference: formalism and algorithms for describing discord and inferring taxonomic roots. Algorithms Mol Biol (2012) 0.85
Topographical and temporal diversity of the human skin microbiome. Science (2009) 15.96
A diversity profile of the human skin microbiota. Genome Res (2008) 7.65
Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing. Sci Transl Med (2012) 6.63
The skin microbiome. Nat Rev Microbiol (2011) 5.78
Early-onset stroke and vasculopathy associated with mutations in ADA2. N Engl J Med (2014) 4.70
Compartmentalized control of skin immunity by resident commensals. Science (2012) 4.19
Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis. Genome Res (2012) 3.71
Topographic diversity of fungal and bacterial communities in human skin. Nature (2013) 2.79
Evolving strategies for the management of hand-foot skin reaction associated with the multitargeted kinase inhibitors sorafenib and sunitinib. Oncologist (2008) 2.22
Bridging the translational research gap: a successful partnership involving a physician and a basic scientist. J Invest Dermatol (2010) 2.11
Keratoacanthomas associated with sorafenib therapy. J Am Acad Dermatol (2007) 1.89
Longitudinal shift in diabetic wound microbiota correlates with prolonged skin defense response. Proc Natl Acad Sci U S A (2010) 1.79
Ectopic expression of kruppel like factor 4 (Klf4) accelerates formation of the epidermal permeability barrier. Development (2003) 1.64
The human microbiome: our second genome. Annu Rev Genomics Hum Genet (2012) 1.64
Transcriptional control of epidermal specification and differentiation. Curr Opin Genet Dev (2004) 1.63
Conservation and the microbiome. Conserv Biol (2012) 1.48
Hand-foot skin reaction increases with cumulative sorafenib dose and with combination anti-vascular endothelial growth factor therapy. Clin Cancer Res (2009) 1.46
Staphylococcus epidermidis pan-genome sequence analysis reveals diversity of skin commensal and hospital infection-associated isolates. Genome Biol (2012) 1.38
The altered landscape of the human skin microbiome in patients with primary immunodeficiencies. Genome Res (2013) 1.35
Klf4 and corticosteroids activate an overlapping set of transcriptional targets to accelerate in utero epidermal barrier acquisition. Proc Natl Acad Sci U S A (2006) 1.35
KLF4 suppresses transformation of pre-B cells by ABL oncogenes. Blood (2006) 1.33
The neuropathic diabetic foot ulcer microbiome is associated with clinical factors. Diabetes (2012) 1.31
Lipid defect underlies selective skin barrier impairment of an epidermal-specific deletion of Gata-3. J Cell Biol (2006) 1.28
Mouse Sprr locus: a tandem array of coordinately regulated genes. Mamm Genome (2003) 1.24
Connexin 26 regulates epidermal barrier and wound remodeling and promotes psoriasiform response. J Clin Invest (2006) 1.22
Interaction of the microbiome with the innate immune response in chronic wounds. Adv Exp Med Biol (2012) 1.21
Sorafenib-induced eruptive melanocytic lesions. Arch Dermatol (2008) 1.21
Diminished allergic disease in patients with STAT3 mutations reveals a role for STAT3 signaling in mast cell degranulation. J Allergy Clin Immunol (2013) 1.19
Skin microbiome: looking back to move forward. J Invest Dermatol (2011) 1.14
Tetracycline-regulated transactivators driven by the involucrin promoter to achieve epidermal conditional gene expression. J Invest Dermatol (2004) 1.08
Strain-dependent perinatal lethality of Ovol1-deficient mice and identification of Ovol2 as a downstream target of Ovol1 in skin epidermis. Biochim Biophys Acta (2006) 1.07
Matriptase-deficient mice exhibit ichthyotic skin with a selective shift in skin microbiota. J Invest Dermatol (2009) 1.01
Genomic insights into the fate of colistin resistance and Acinetobacter baumannii during patient treatment. Genome Res (2013) 1.00
A milieu of regulatory elements in the epidermal differentiation complex syntenic block: implications for atopic dermatitis and psoriasis. Hum Mol Genet (2010) 0.99
Long-range comparison of human and mouse Sprr loci to identify conserved noncoding sequences involved in coordinate regulation. Genome Res (2004) 0.97
Modeling atopic dermatitis with increasingly complex mouse models. J Invest Dermatol (2008) 0.88
Pan-PCR, a computational method for designing bacterium-typing assays based on whole-genome sequence data. J Clin Microbiol (2012) 0.83
Helminth infection is associated with decreased basophil responsiveness in human beings. J Allergy Clin Immunol (2012) 0.82
An Amish boy with recurrent ulcerations of the lower extremities, telangiectases of the hands, and chronic lung disease. J Am Acad Dermatol (2010) 0.80
Lack of association between excretion of sorafenib in sweat and hand-foot skin reaction. Pharmacotherapy (2010) 0.79
Array of cutaneous adverse effects associated with sorafenib. J Am Acad Dermatol (2009) 0.79
Successful laser treatment of vandetanib-associated cutaneous pigmentation. Arch Dermatol (2011) 0.78
Novel assessment tools to evaluate clinical and laboratory responses in a subset of patients enrolled in the Rituximab in Myositis trial. Clin Exp Rheumatol (2014) 0.78
Genomics: Resident risks. Nature (2012) 0.75
Navigating the genome. J Cell Sci (2008) 0.75